Fosun International LTD Ambrx Biopharma Inc. Transaction History

Fosun International LTD

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 Apr 28, 2023	SELL	$1.46 - $12.54 $2.46 Million - $21.1 Million	-1,683,401 Reduced 87.11%	249,190 $2.22 Million
Q2 2021 Aug 12, 2021	BUY	$15.95 - $19.6 $30.8 Million - $37.9 Million	1,932,591 New	1,932,591 $37.9 Million

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.